To: | Genomic Health, Inc. (tmadmin@kilpatricktownsend.com) |
Subject: | U.S. TRADEMARK APPLICATION NO. 88278751 - ODXI-IBC - 1124150 |
Sent: | 4/17/2019 11:00:45 AM |
Sent As: | ECOM128@USPTO.GOV |
Attachments: |
UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO)
OFFICE ACTION (OFFICIAL LETTER) ABOUT APPLICANT’S TRADEMARK APPLICATION
U.S. APPLICATION SERIAL NO. 88278751
MARK: ODXI-IBC
|
|
CORRESPONDENT ADDRESS: |
GENERAL TRADEMARK INFORMATION: http://www.gov.uspto.report/trademarks/index.jsp
|
APPLICANT: Genomic Health, Inc.
|
|
CORRESPONDENT’S REFERENCE/DOCKET NO: CORRESPONDENT E-MAIL ADDRESS: |
|
EXAMINER’S AMENDMENT
ISSUE/MAILING DATE: 4/17/2019
DATABASE SEARCH: The trademark examining attorney has searched the USPTO’s database of registered and pending marks and has found no conflicting marks that would bar registration under Trademark Act Section 2(d). TMEP §704.02; see 15 U.S.C. §1052(d).
APPLICATION HAS BEEN AMENDED: In accordance with the authorization granted by Margaret McHugh on April 16, 2019, the trademark examining attorney has amended the application as indicated below. Please advise the undersigned immediately of any objections. Otherwise, no response is necessary. TMEP §707. Any amendments to the identification of goods and/or services may clarify or limit the goods and/or services, but may not add to or broaden the scope of the goods and/or services. 37 C.F.R. §2.71(a); see TMEP §§1402.06 et seq.
The identification of goods in Class 5 is amended to read as follows:
“Diagnostic kits comprised of medical diagnostic reagents and diagnostic assays for testing tissue samples for use in cancer detection, analysis and prognosis; medical diagnostic reagents; diagnostic kits consisting primarily of enzymes for medical purposes, nucleic acids, buffers, reagents and assays for use in disease testing; medical diagnostic assays for testing tissue for medical and prognostic purposes; medical diagnostic reagents and assays for testing tissue samples for use in disease detection, namely, cancer; enzyme preparations for medical purposes; biological preparations for the detection, diagnosis and monitoring of cancer for medical purposes; preparations for detecting genetic predispositions for medical purposes; biological preparations for use in the diagnosis, analysis and prognosis of cancer for medical purposes; diagnostic agents, preparations and substances for medical purposes.”
See TMEP §§1402.01, 1402.01(e).
/Bridget Watson/
Bridget Watson
Trademark Law Clerk
Law Office 128
(571) 272-7163
bridget.watson@uspto.gov
PERIODICALLY CHECK THE STATUS OF THE APPLICATION: To ensure that applicant does not miss crucial deadlines or official notices, check the status of the application every three to four months using the Trademark Status and Document Retrieval (TSDR) system at http://tsdr.gov.uspto.report/. Please keep a copy of the TSDR status screen. If the status shows no change for more than six months, contact the Trademark Assistance Center by e-mail at TrademarkAssistanceCenter@uspto.gov or call 1-800-786-9199. For more information on checking status, see http://www.gov.uspto.report/trademarks/process/status/.
TO UPDATE CORRESPONDENCE/E-MAIL ADDRESS: Use the Trademark Electronic Application System (TEAS) form at http://www.gov.uspto.report/trademarks/teas/correspondence.jsp.